• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Relationship between angiotensin-(1-7) and angiotensin II correlates with hemodynamic changes in human liver cirrhosis.血管紧张素 -(1 - 7)与血管紧张素 II 之间的关系与人类肝硬化的血流动力学变化相关。
World J Gastroenterol. 2009 May 28;15(20):2512-9. doi: 10.3748/wjg.15.2512.
2
Effect of propranolol on the splanchnic and peripheral renin angiotensin system in cirrhotic patients.普萘洛尔对肝硬化患者内脏和外周肾素-血管紧张素系统的影响。
World J Gastroenterol. 2008 Nov 28;14(44):6824-30. doi: 10.3748/wjg.14.6824.
3
Angiotensin-(1-7), an alternative metabolite of the renin-angiotensin system, is up-regulated in human liver disease and has antifibrotic activity in the bile-duct-ligated rat.血管紧张素 -(1 - 7)是肾素 - 血管紧张素系统的一种代谢产物,在人类肝脏疾病中表达上调,并且在胆管结扎的大鼠中具有抗纤维化活性。
Clin Sci (Lond). 2009 Sep 14;117(11):375-86. doi: 10.1042/CS20080647.
4
Circulating renin Angiotensin system in childhood chronic renal failure: marked increase of Angiotensin-(1-7) in end-stage renal disease.儿童慢性肾衰竭中的循环肾素-血管紧张素系统:终末期肾病中血管紧张素-(1-7)显著增加。
Pediatr Res. 2006 Dec;60(6):734-9. doi: 10.1203/01.pdr.0000246100.14061.bc. Epub 2006 Oct 25.
5
Activation of the MAS receptor by angiotensin-(1-7) in the renin-angiotensin system mediates mesenteric vasodilatation in cirrhosis.血管紧张素转化酶 2 抑制剂对肝硬化大鼠肠系膜动脉血管张力及自发性高血压大鼠血压的影响
Gastroenterology. 2013 Oct;145(4):874-884.e5. doi: 10.1053/j.gastro.2013.06.036. Epub 2013 Jun 22.
6
Elevated Angiotensin 1-7/Angiotensin II Ratio Predicts Favorable Outcomes in Patients With Heart Failure.血管紧张素 1-7/血管紧张素 II 比值升高可预测心力衰竭患者的良好结局。
Circ Heart Fail. 2020 Jul;13(7):e006939. doi: 10.1161/CIRCHEARTFAILURE.120.006939. Epub 2020 Jun 25.
7
The renin angiotensin system in childhood hypertension: selective increase of angiotensin-(1-7) in essential hypertension.儿童高血压中的肾素血管紧张素系统:原发性高血压中血管紧张素 -(1 - 7)的选择性增加。
J Pediatr. 2004 Jul;145(1):93-8. doi: 10.1016/j.jpeds.2004.03.055.
8
Altered Serum Levels of Renin-Angiotensin System Markers in Migraine.偏头痛患者血清肾素-血管紧张素系统标志物水平的改变
Headache. 2020 Oct;60(9):1995-2002. doi: 10.1111/head.13949. Epub 2020 Sep 2.
9
Measurement of Angiotensin Peptides: HPLC-RIA.血管紧张素肽的测定:高效液相色谱-放射免疫分析法
Methods Mol Biol. 2017;1527:81-99. doi: 10.1007/978-1-4939-6625-7_7.
10
Downregulation of the vascular renin-angiotensin system by aerobic training - focus on the balance between vasoconstrictor and vasodilator axes - .有氧运动训练对血管肾素-血管紧张素系统的下调作用——关注血管收缩轴与血管舒张轴之间的平衡——
Circ J. 2015;79(6):1372-80. doi: 10.1253/circj.CJ-14-1179. Epub 2015 Mar 25.

引用本文的文献

1
Hepatorenal Syndrome: A Critical Complication in Advanced Cirrhosis.肝肾综合征:晚期肝硬化的一种严重并发症。
Cureus. 2025 Jun 6;17(6):e85488. doi: 10.7759/cureus.85488. eCollection 2025 Jun.
2
Molecular dissection of the role of ACE2 in glucose homeostasis.血管紧张素转换酶2(ACE2)在葡萄糖稳态中作用的分子剖析
Physiol Rev. 2025 Jul 1;105(3):935-973. doi: 10.1152/physrev.00027.2024. Epub 2025 Feb 7.
3
The Renin-Angiotensin System in Liver Disease.肝疾病中的肾素-血管紧张素系统。
Int J Mol Sci. 2024 May 27;25(11):5807. doi: 10.3390/ijms25115807.
4
The Contemporary Role of Speckle Tracking Echocardiography in Cirrhotic Cardiomyopathy.斑点追踪超声心动图在肝硬化性心肌病中的当代作用
Life (Basel). 2024 Jan 25;14(2):179. doi: 10.3390/life14020179.
5
Insight into the hepatoprotective, hypolipidemic, and antidiabetic impacts of aliskiren in streptozotocin-induced diabetic liver disease in mice.阿利吉仑对链脲佐菌素诱导的小鼠糖尿病肝病的肝保护、降血脂和抗糖尿病作用的研究。
Diabetol Metab Syndr. 2022 Oct 31;14(1):163. doi: 10.1186/s13098-022-00935-5.
6
Mas-related G protein-coupled receptor type D antagonism improves portal hypertension in cirrhotic rats.Mas 相关 G 蛋白偶联受体 D 型拮抗作用改善肝硬化大鼠的门静脉高压。
Hepatol Commun. 2022 Sep;6(9):2523-2537. doi: 10.1002/hep4.1987. Epub 2022 May 20.
7
Update on New Aspects of the Renin-Angiotensin System in Hepatic Fibrosis and Portal Hypertension: Implications for Novel Therapeutic Options.肝纤维化和门静脉高压中肾素-血管紧张素系统新进展:对新型治疗选择的启示
J Clin Med. 2021 Feb 11;10(4):702. doi: 10.3390/jcm10040702.
8
Cirrhotic portal hypertension: From pathophysiology to novel therapeutics.肝硬化门静脉高压症:从病理生理学到新疗法。
World J Gastroenterol. 2020 Oct 28;26(40):6111-6140. doi: 10.3748/wjg.v26.i40.6111.
9
Hepatorenal syndrome in children: a review.儿童肝肾综合征综述
Pediatr Nephrol. 2021 Aug;36(8):2203-2215. doi: 10.1007/s00467-020-04762-6. Epub 2020 Oct 1.
10
Interplay of cardiovascular mediators, oxidative stress and inflammation in liver disease and its complications.心血管介质、氧化应激和炎症在肝脏疾病及其并发症中的相互作用。
Nat Rev Cardiol. 2021 Feb;18(2):117-135. doi: 10.1038/s41569-020-0433-5. Epub 2020 Sep 30.

本文引用的文献

1
Effect of propranolol on the splanchnic and peripheral renin angiotensin system in cirrhotic patients.普萘洛尔对肝硬化患者内脏和外周肾素-血管紧张素系统的影响。
World J Gastroenterol. 2008 Nov 28;14(44):6824-30. doi: 10.3748/wjg.14.6824.
2
Liver fibrosis: a balance of ACEs?肝纤维化:血管紧张素转换酶的平衡?
Clin Sci (Lond). 2007 Aug;113(3):109-18. doi: 10.1042/CS20070026.
3
Upregulation of hepatic angiotensin-converting enzyme 2 (ACE2) and angiotensin-(1-7) levels in experimental biliary fibrosis.实验性胆汁性肝纤维化中肝血管紧张素转换酶2(ACE2)及血管紧张素-(1-7)水平的上调
J Hepatol. 2007 Sep;47(3):387-95. doi: 10.1016/j.jhep.2007.03.008. Epub 2007 Apr 2.
4
Advances in the pathogenesis and treatment of type-1 and type-2 hepatorenal syndrome.1型和2型肝肾综合征的发病机制及治疗进展
J Hepatol. 2007 May;46(5):935-46. doi: 10.1016/j.jhep.2007.02.001. Epub 2007 Feb 27.
5
Vascular endothelial dysfunction in cirrhosis.肝硬化中的血管内皮功能障碍
J Hepatol. 2007 May;46(5):927-34. doi: 10.1016/j.jhep.2007.02.006. Epub 2007 Mar 5.
6
Angiotensin-(1-7) and the renin-angiotensin system.血管紧张素-(1-7)与肾素-血管紧张素系统
Curr Opin Nephrol Hypertens. 2007 Mar;16(2):122-8. doi: 10.1097/MNH.0b013e328031f362.
7
The pregnancy-induced increase of plasma angiotensin-(1-7) is blunted in gestational diabetes.妊娠期糖尿病患者孕期血浆血管紧张素 -(1 - 7)的升高受到抑制。
Regul Pept. 2007 Jun 7;141(1-3):55-60. doi: 10.1016/j.regpep.2006.12.014. Epub 2007 Jan 4.
8
The renin-angiotensin system in a rat model of hepatic fibrosis: evidence for a protective role of Angiotensin-(1-7).肝纤维化大鼠模型中的肾素-血管紧张素系统:血管紧张素-(1-7)具有保护作用的证据
J Hepatol. 2007 Apr;46(4):674-81. doi: 10.1016/j.jhep.2006.10.018. Epub 2006 Nov 27.
9
The therapeutic potential of Angiotensin-(1-7) as a novel Renin-Angiotensin System mediator.血管紧张素-(1-7)作为肾素-血管紧张素系统新型介质的治疗潜力。
Mini Rev Med Chem. 2006 May;6(5):603-9. doi: 10.2174/138955706776876203.
10
The effects of treatment with octreotide, diuretics, or both on portal hemodynamics in nonazotemic cirrhotic patients with ascites.奥曲肽、利尿剂或两者联合治疗对非氮质血症肝硬化腹水患者门静脉血流动力学的影响。
J Clin Gastroenterol. 2006 Apr;40(4):342-6. doi: 10.1097/01.mcg.0000210101.74618.61.

血管紧张素 -(1 - 7)与血管紧张素 II 之间的关系与人类肝硬化的血流动力学变化相关。

Relationship between angiotensin-(1-7) and angiotensin II correlates with hemodynamic changes in human liver cirrhosis.

作者信息

Vilas-Boas Walkíria Wingester, Ribeiro-Oliveira Antônio, Pereira Regina Maria, Ribeiro Renata da Cunha, Almeida Jerusa, Nadu Ana Paula, Simões e Silva Ana Cristina, dos Santos Robson Augusto Souza

机构信息

Department of Physiology, Laboratory of Hypertension, Biological Sciences institute, Federal University of Minas Gerais, Belo Horizonte, MG, Brazil.

出版信息

World J Gastroenterol. 2009 May 28;15(20):2512-9. doi: 10.3748/wjg.15.2512.

DOI:10.3748/wjg.15.2512
PMID:19469002
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2686910/
Abstract

AIM

To measure circulating angiotensins at different stages of human cirrhosis and to further evaluate a possible relationship between renin angiotensin system (RAS) components and hemodynamic changes.

METHODS

Patients were allocated into 4 groups: mild-to-moderate liver disease (MLD), advanced liver disease (ALD), patients undergoing liver transplantation, and healthy controls. Blood was collected to determine plasma renin activity (PRA), angiotensin (Ang) I, Ang II, and Ang-(1-7) levels using radioimmunoassays. During liver transplantation, hemodynamic parameters were determined and blood was simultaneously obtained from the portal vein and radial artery in order to measure RAS components.

RESULTS

PRA and angiotensins were elevated in ALD when compared to MLD and controls (P < 0.05). In contrast, Ang II was significantly reduced in MLD. Ang-(1-7)/Ang II ratios were increased in MLD when compared to controls and ALD. During transplantation, Ang II levels were lower and Ang-(1-7)/Ang II ratios were higher in the splanchnic circulation than in the peripheral circulation (0.52 +/- 0.08 vs 0.38 +/- 0.04, P < 0.02), whereas the peripheral circulating Ang II/Ang I ratio was elevated in comparison to splanchnic levels (0.18 +/- 0.02 vs 0.13 +/- 0.02, P < 0.04). Ang-(1-7)/Ang II ratios positively correlated with cardiac output (r = 0.66) and negatively correlated with systemic vascular resistance (r = -0.70).

CONCLUSION

Our findings suggest that the relationship between Ang-(1-7) and Ang II may play a role in the hemodynamic changes of human cirrhosis.

摘要

目的

测定人类肝硬化不同阶段循环血管紧张素水平,并进一步评估肾素血管紧张素系统(RAS)各组分与血流动力学变化之间的可能关系。

方法

将患者分为4组:轻度至中度肝病(MLD)组、晚期肝病(ALD)组、肝移植患者组和健康对照组。采集血液,采用放射免疫分析法测定血浆肾素活性(PRA)、血管紧张素(Ang)I、Ang II和Ang-(1-7)水平。在肝移植过程中,测定血流动力学参数,并同时从门静脉和桡动脉采集血液以测量RAS各组分。

结果

与MLD组和对照组相比,ALD组的PRA和血管紧张素水平升高(P < 0.05)。相反,MLD组的Ang II显著降低。与对照组和ALD组相比,MLD组的Ang-(1-7)/Ang II比值升高。在移植过程中,内脏循环中的Ang II水平低于外周循环,而Ang-(1-7)/Ang II比值高于外周循环(0.52±0.08对0.38±0.04,P < 0.02),而外周循环中的Ang II/Ang I比值与内脏水平相比升高(0.18±0.02对0.13±0.02,P < 0.04)。Ang-(1-7)/Ang II比值与心输出量呈正相关(r = 0.66),与全身血管阻力呈负相关(r = -0.70)。

结论

我们的研究结果表明,Ang-(1-7)与Ang II之间的关系可能在人类肝硬化的血流动力学变化中起作用。